EXELON

Identification of Exelon

No description

Google image searchProduct monograph

Active ingredient

rivastigmine (rivastigmine hydrogen tartrate), 1.5 MG

DIN: 02242115

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: KNIGHT THERAPEUTICS INC.

Date: 24-NOV-2022

ATC:

Reference brand drug: Exelon

Pharmaceutical standard: MFR

Search on Google